{
  "ticker": "CHRS",
  "company_name": "Coherus Oncology, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07277322",
      "title": "Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Colorectal Cancer, Liver Metastases",
      "start_date": "2025-12-15",
      "completion_date": "2030-12-16",
      "enrollment": 0,
      "sponsor": "Dan Feng"
    },
    {
      "nct_id": "NCT07209189",
      "title": "Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE2",
      "condition": "Head and Neck Cancer, Squamous Cell Carcinoma, Oral Cavity Cancer, Oropharyngeal Cancer, Laryngeal Cancer, Sinonasal Squamous Cell Carcinoma, HPV (Human Papillomavirus)-Associated Carcinoma, Skull Base Tumors, HPV 16 Positive Oropharyngeal Tumors (OPC)",
      "start_date": "2026-01-15",
      "completion_date": "2030-12-01",
      "enrollment": 0,
      "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"
    },
    {
      "nct_id": "NCT06657144",
      "title": "A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Metastatic Solid Tumor, Advanced Solid Tumor",
      "start_date": "2025-04-01",
      "completion_date": "2027-05",
      "enrollment": 0,
      "sponsor": "Coherus Oncology, Inc."
    },
    {
      "nct_id": "NCT06389526",
      "title": "A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1",
      "condition": "Advanced or Metastatic Solid Tumors",
      "start_date": "2025-02-15",
      "completion_date": "2028-05-30",
      "enrollment": 0,
      "sponsor": "Coherus Oncology, Inc."
    },
    {
      "nct_id": "NCT02489227",
      "title": "Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Plaque Psoriasis",
      "start_date": "2015-08",
      "completion_date": "2017-03",
      "enrollment": 0,
      "sponsor": "Coherus Oncology, Inc."
    },
    {
      "nct_id": "NCT02650973",
      "title": "Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2016-02",
      "completion_date": "2016-06",
      "enrollment": 0,
      "sponsor": "Coherus Oncology, Inc."
    },
    {
      "nct_id": "NCT02418104",
      "title": "Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta\u00ae",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Immunity, Humoral",
      "start_date": "2015-05",
      "completion_date": "2015-12",
      "enrollment": 0,
      "sponsor": "Coherus Oncology, Inc."
    },
    {
      "nct_id": "NCT07281716",
      "title": "Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Microsatellite Stable Colorectal Carcinoma",
      "start_date": "2025-12",
      "completion_date": "2028-12-15",
      "enrollment": 0,
      "sponsor": "Dan Feng"
    },
    {
      "nct_id": "NCT04662892",
      "title": "An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca",
      "status": "UNKNOWN",
      "phase": "",
      "condition": "Febrile Neutropenia, Non-myeloid Malignancy",
      "start_date": "2020-08-01",
      "completion_date": "2022-12-15",
      "enrollment": 0,
      "sponsor": "Coherus Oncology, Inc."
    },
    {
      "nct_id": "NCT06940180",
      "title": "Toripalimab With Chemotherapy for Sinus Cancer",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Sinonasal Cancer, Paranasal Sinus Neoplasms, Squamous Cell Carcinoma, Sinonasal Undifferentiated Carcinoma, Locally Advanced Head and Neck Cancer",
      "start_date": "2025-06-17",
      "completion_date": "2029-02-01",
      "enrollment": 0,
      "sponsor": "Glenn J. Hanna"
    }
  ],
  "summary": {
    "total_trials": 26,
    "by_phase": {
      "PHASE1, PHASE2": 3,
      "PHASE2": 8,
      "PHASE1": 9,
      "PHASE3": 4,
      "": 1,
      "PHASE4": 1
    },
    "by_status": {
      "NOT_YET_RECRUITING": 6,
      "RECRUITING": 7,
      "COMPLETED": 10,
      "UNKNOWN": 1,
      "TERMINATED": 2
    },
    "active_trials": 7,
    "completed_trials": 10,
    "conditions": [
      "Advanced Solid Tumor",
      "Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma, Non-small Cell Lung Cancer",
      "Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma",
      "Advanced Solid Tumor, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma",
      "Advanced or Metastatic Solid Tumors",
      "Bioequivalence",
      "Febrile Neutropenia, Non-myeloid Malignancy",
      "Head and Neck Cancer, Squamous Cell Carcinoma, Oral Cavity Cancer, Oropharyngeal Cancer, Laryngeal Cancer, Sinonasal Squamous Cell Carcinoma, HPV (Human Papillomavirus)-Associated Carcinoma, Skull Base Tumors, HPV 16 Positive Oropharyngeal Tumors (OPC)",
      "Healthy",
      "Hepatocellular Carcinoma",
      "Immunity, Humoral",
      "Localized Colon Carcinoma, Stage IIB Colon Cancer AJCC v8, Stage IIC Colon Cancer AJCC v8, Stage III Colon Cancer AJCC v8",
      "Metastatic Castration-resistant Prostate Cancer, Prostate Cancer",
      "Metastatic Colorectal Cancer, Liver Metastases",
      "Metastatic Microsatellite Stable Colorectal Carcinoma",
      "Metastatic Non-small Cell Lung Cancer, Metastatic Melanoma, Metastatic Endometrial Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma, Solid Tumor",
      "Metastatic Solid Tumor, Advanced Solid Tumor",
      "Nasopharyngeal Cancer Recurrent",
      "Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3",
      "Plaque Psoriasis",
      "Rheumatoid Arthritis",
      "Rheumatoid Arthritis, Plaque Psoriasis",
      "Sinonasal Cancer, Paranasal Sinus Neoplasms, Squamous Cell Carcinoma, Sinonasal Undifferentiated Carcinoma, Locally Advanced Head and Neck Cancer",
      "Squamous Cell Carcinoma, Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:28.037911",
    "search_query": "Coherus Oncology, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Coherus+Oncology,+Inc."
  }
}